Suzhou Basecare Medical IPO: Trading Debut
Basecare priced its IPO at HK$27.36 and closed 14% up at HK$31.20 in the grey market. Our DCF sensitivity analysis shows that the IPO price is...
361 Views
ECM Weekly (7 February 2021) - Kuaishou, New Horizon, SciClone, Cloopen
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
341 Views
New Horizon IPO: Only Undemanding Assumptions Needed
We think the proposed valuation of New Horizon Health's (NHH HK) IPO is reasonable using undemanding assumptions and would participate in the...
383 Views
New Horizon Health (诺辉健康) IPO: Room to Fly
We think there is substantial upside from the high end. The line-up of cornerstone investors is strong. We are seeing strong demand from...
1.9k Views
New Horizon Health IPO: Valuation Insights
New Horizon will raise gross proceeds of $244 million at the mid-point of the proposed IPO price range of HK$22.70-26.66. We would participate in...
1k Views